Large-scale association analysis identifies 13 new susceptibility loci for coronary artery diseaseStephen E. Epstein, Karl Andersen, Jeffrey L. Anderson et al.|Nature Genetics|2011Cited by 2k
Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With StatinsS. Matthijs Boekholdt, John J.P. Kastelein, Benoît J. Arsenault et al.|JAMA|2012Cited by 800
Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin TreatmentS. Matthijs Boekholdt, J Kastelein, Frank M. Sacks et al.|Circulation|2005Cited by 310
Distribution of Estimated 10-Year Risk of Recurrent Vascular Events and Residual Risk in a Secondary Prevention PopulationLotte Kaasenbrood, Frank L.J. Visseren, S. Matthijs Boekholdt et al.|Circulation|2016Cited by 275
Variants of Toll-Like Receptor 4 Modify the Efficacy of Statin Therapy and the Risk of Cardiovascular EventsS. Matthijs Boekholdt, J. Wouter Jukema, Willem R.P. Agema et al.|Circulation|2003Cited by 226